Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC687120836;20837;20838 chr2:178725593;178725592;178725591chr2:179590320;179590319;179590318
N2AB655419885;19886;19887 chr2:178725593;178725592;178725591chr2:179590320;179590319;179590318
N2A562717104;17105;17106 chr2:178725593;178725592;178725591chr2:179590320;179590319;179590318
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Ig-53
  • Domain position: 18
  • Structural Position: 28
  • Q(SASA): 0.3238
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T rs745807060 -1.034 0.183 N 0.537 0.131 0.119812018005 gnomAD-2.1.1 4.07E-06 None None None None N None 6.49E-05 0 None 0 0 None 0 None 0 0 0
A/T rs745807060 -1.034 0.183 N 0.537 0.131 0.119812018005 gnomAD-3.1.2 6.57E-06 None None None None N None 2.41E-05 0 0 0 0 None 0 0 0 0 0
A/T rs745807060 -1.034 0.183 N 0.537 0.131 0.119812018005 gnomAD-4.0.0 2.57169E-06 None None None None N None 3.39029E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.4683 ambiguous 0.4787 ambiguous -0.964 Destabilizing 0.836 D 0.644 neutral None None None None N
A/D 0.8778 likely_pathogenic 0.8718 pathogenic -1.154 Destabilizing 0.921 D 0.703 prob.neutral N 0.478764028 None None N
A/E 0.75 likely_pathogenic 0.7424 pathogenic -1.075 Destabilizing 0.593 D 0.673 neutral None None None None N
A/F 0.4698 ambiguous 0.4789 ambiguous -0.69 Destabilizing 0.716 D 0.699 prob.neutral None None None None N
A/G 0.2628 likely_benign 0.2484 benign -1.265 Destabilizing 0.523 D 0.547 neutral N 0.478257048 None None N
A/H 0.8669 likely_pathogenic 0.8595 pathogenic -1.439 Destabilizing 0.983 D 0.683 prob.neutral None None None None N
A/I 0.189 likely_benign 0.1786 benign 0.053 Stabilizing 0.049 N 0.454 neutral None None None None N
A/K 0.8512 likely_pathogenic 0.851 pathogenic -1.157 Destabilizing 0.593 D 0.643 neutral None None None None N
A/L 0.2021 likely_benign 0.2088 benign 0.053 Stabilizing None N 0.33 neutral None None None None N
A/M 0.2594 likely_benign 0.2422 benign -0.099 Destabilizing 0.061 N 0.391 neutral None None None None N
A/N 0.7836 likely_pathogenic 0.7576 pathogenic -1.072 Destabilizing 0.94 D 0.701 prob.neutral None None None None N
A/P 0.8497 likely_pathogenic 0.8719 pathogenic -0.213 Destabilizing 0.921 D 0.723 prob.delet. N 0.478510538 None None N
A/Q 0.7455 likely_pathogenic 0.7381 pathogenic -1.046 Destabilizing 0.836 D 0.715 prob.delet. None None None None N
A/R 0.7804 likely_pathogenic 0.7904 pathogenic -1.02 Destabilizing 0.836 D 0.723 prob.delet. None None None None N
A/S 0.2037 likely_benign 0.1897 benign -1.547 Destabilizing 0.351 N 0.563 neutral N 0.478257048 None None N
A/T 0.1128 likely_benign 0.107 benign -1.337 Destabilizing 0.183 N 0.537 neutral N 0.48403258 None None N
A/V 0.0821 likely_benign 0.0822 benign -0.213 Destabilizing 0.001 N 0.155 neutral N 0.371915009 None None N
A/W 0.8994 likely_pathogenic 0.9042 pathogenic -1.183 Destabilizing 0.983 D 0.709 prob.delet. None None None None N
A/Y 0.7747 likely_pathogenic 0.765 pathogenic -0.688 Destabilizing 0.836 D 0.697 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.